Weight-loss drugs drive increase in male cosmetic procedures

The widespread use of GLP-1 weight-loss medications, such as Wegovy and Zepbound, is driving a surge in demand for cosmetic procedures among men. As patients lose significant weight, many are seeking treatments to address physical changes like sagging skin, facial volume loss, and hair loss.

Plastic surgeons report a notable increase in male clientele, with some seeing a doubling of male patients over the last two years. While women remain the primary demographic for aesthetic treatments, men underwent approximately 1.7 million cosmetic procedures in 2024.

In response to the side effects and administration methods of traditional weight-loss drugs, new formulations are emerging. Some providers are developing needle-free, sublingual Tirzepatide tablets combined with vitamins B6 and B12, designed to target metabolic pathways while potentially reducing common side effects like nausea.